Man Xia
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- MicroRNA in disease regulation 2
- Co-authors
- Chaohui Zuo (13 shared papers)Haizhen Zhu (8 shared papers)Hailong Xie (4 shared papers)Hongyu Deng (4 shared papers)Hui Zeng (1 shared paper)Xiaohong Wang (3 shared papers)Renyun Tian (1 shared paper)Jinfeng Wang (1 shared paper)
- Journals
- Cancer Medicine (1 paper)Analytical Cellular Pathology (1 paper)Oncotarget (1 paper)International Journal of Nanomedicine (1 paper)Molecular Therapy (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Man Xia
15 papers receiving 397 citations
Peers
Comparison fields: 5 of 44
- Hepatology 45
- Cancer Research 62
- Genetics 30
- Molecular Biology 182
- Oncology 47
Countries citing papers authored by Man Xia
This map shows the geographic impact of Man Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Xia more than expected).
Fields of papers citing papers by Man Xia
This network shows the impact of papers produced by Man Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Xia. The network helps show where Man Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 2017 | 81 | |
| 3 | 2016 | 42 | |
| 4 | 2017 | 32 | |
| 5 | ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma. | 2015 | 22 |
| 6 | 2018 | 21 | |
| 7 | 2014 | 17 | |
| 8 | 2019 | 17 | |
| 9 | 2015 | 16 | |
| 10 | Clavien-Dindo classification and risk factors of gastrectomy-related complications: an analysis of 1049 patients. | 2015 | 13 |
| 11 | 2015 | 13 | |
| 12 | 2015 | 10 | |
| 13 | 2013 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2024 | 5 |
About Man Xia
Man Xia is a scholar working on Hepatology, Cancer Research, Molecular Biology, Immunology and Oncology, having authored 15 papers that have together received 403 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (2 papers), RNA Interference and Gene Delivery (1 paper), Inflammatory mediators and NSAID effects (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (45 citations), Cancer Research (62 citations), Genetics (30 citations), Molecular Biology (182 citations) and Oncology (47 citations). Man Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chaohui Zuo, Haizhen Zhu, Hailong Xie, Hongyu Deng, Hui Zeng, Xiaohong Wang, Renyun Tian, Jinfeng Wang, Chen Liu and Min Ma. Their work appears in journals such as Cancer Medicine, Analytical Cellular Pathology, Oncotarget, International Journal of Nanomedicine and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.